It's really a nootropic drug invented in 1996 by a staff Functioning for Merck, Sharp and Dohme, that was the main compound designed which functions for a subtype-selective inverse agonist on the ?5 subtype of your benzodiazepine binding web site over the GABAA receptor.From assessment in the methylphenidate synthesis literature, it appeared plausi